Bahram Alamdary Badlou
CEO and Medical Advisor
BBAdvies and Research
The Netherlands
Bahram Alamdary Badlou is working as CEO and Medical Advisor at BBAdvies and Research and BBARinternational, Zeist, Netherlands. Dr Badlou is for more than 15 years in the Cell Biologic research, Clinical and Experimental Heart Transplantation , Plasma proteins, Cardivascular Research, Immunocytochemistry, molecular biology, Haemostasis and metabolism, Transfusion Medicine, Hemophilia, Bleedings disorders, Human and Animal (Rodents) heart surgery, Heart and Pancreatic tissue preparation, Stem cells transplantation, Human Patho-physiology, and primary cell cultures. Dr Badlou and his group interest is focused on Transfusion, Transplantation Sciences and metabolism effects against ageing related diseases.
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report